Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases

[1] Gavrilovic IT(2005)Brain metastases: epidemiology and pathophysiology J Neurooncol 75 5-14

[2] Posner JB(2002)Symptom response after palliative radiotherapy for patients with brain metastases Eur J Cancer 38 487-496

[3] Bezjak A(2012)Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases Cochrane Database Syst Rev 4 533-540

[4] Adam J(2003)The management of brain metastases Cancer Treat Rev 29 210-225

[5] Barton R(2012)Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline Pract Radiat Oncol 2 71-83

[6] Panzarella T(2010)The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline J Neurooncol 96 25-45

[7] Laperriere N(2008)Quality of life in brain metastases radiation trials: a literature review Curr Oncol 15 693-700

[8] Wong CS(2011)The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review Expert Rev Pharmacoecon Outcomes Res 11 407-415

[9] Tsao MN(1989)Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 196-202

[10] Lloyd N(2007)Interpreting clinically significant changes in patient-reported outcomes Cancer 110 2107-2112

[1] Gavrilovic IT(2005)Brain metastases: epidemiology and pathophysiology J Neurooncol 75 5-14

[2] Posner JB(2002)Symptom response after palliative radiotherapy for patients with brain metastases Eur J Cancer 38 487-496

[3] Bezjak A(2012)Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases Cochrane Database Syst Rev 4 533-540

[4] Adam J(2003)The management of brain metastases Cancer Treat Rev 29 210-225

[5] Barton R(2012)Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline Pract Radiat Oncol 2 71-83

[6] Panzarella T(2010)The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline J Neurooncol 96 25-45

[7] Laperriere N(2008)Quality of life in brain metastases radiation trials: a literature review Curr Oncol 15 693-700

[8] Wong CS(2011)The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review Expert Rev Pharmacoecon Outcomes Res 11 407-415

[9] Tsao MN(1989)Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 196-202

[10] Lloyd N(2007)Interpreting clinically significant changes in patient-reported outcomes Cancer 110 2107-2112